ArticleJHEP reports : innovation in hepatology2021

Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation.

Michael Praktiknjo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.